Details for New Drug Application (NDA): 074779
✉ Email this page to a colleague
NDA 074779 describes AKBETA, which is a drug marketed by Epic Pharma Llc and is included in two NDAs. Additional details are available on the AKBETA profile page.
The generic ingredient in AKBETA is levobunolol hydrochloride. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the levobunolol hydrochloride profile page.
The generic ingredient in AKBETA is levobunolol hydrochloride. There are seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the levobunolol hydrochloride profile page.
Summary for 074779
| Tradename: | AKBETA |
| Applicant: | Epic Pharma Llc |
| Ingredient: | levobunolol hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 074779
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.25% | ||||
| Approval Date: | Oct 29, 1996 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
